Alliance A091102: Phase II study of MLN8237 (Alisertib) in advanced/metastatic sarcoma Meeting Abstract

  

Authors:	Dickson, M. A.; Mahoney, M. R.; Tap, W. D.; D'Angelo, S. P.; Keohan, M. L.; Van Tine, B. A.; Agulnik, M.; Horvath, L. E.; Schwartz, G. K.
Abstract Title:	Alliance A091102: Phase II study of MLN8237 (Alisertib) in advanced/metastatic sarcoma
Meeting Title:	50th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title:	Journal of Clinical Oncology
Volume:	32
Issue:	15 Suppl.
Meeting Dates:	2014 May 30-Jun 3
Meeting Location:	Chicago, IL
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2014-05-20
Language:	English
ACCESSION:	WOS:000358613204660
PROVIDER:	wos
DOI:	10.1200/jco.2014.32.15_suppl.10527
Notes:	Meeting Abstract: 10527 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/80881